Monitoring of Donor-specific Antibodies After Treatment with Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Lung TransplantationDonor-specific Anti-human Leukocyte Antigen(HLA) Antibodies

Interventions

DIAGNOSTIC_TEST

blood samples

For performing the Luminex solid phase assay (SPA) test, 7.5 ml of patient whole blood are collected from a peripheral vein.

Trial Locations (1)

RECRUITING

Hannover Medical School, Department of Cardiothoracic, Transplant and Vascular Surgery, Hanover

All Listed Sponsors

lead

Hannover Medical School

OTHER